Prognostic value of metabolic parameters measured by 18F-fluorodeoxyglucose positron emission tomography-computed tomography in surgically resected non-small cell lung cancer patients

MLA

Mathew, Boon, et al. “Prognostic Value of Metabolic Parameters Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Surgically Resected Non-Small Cell Lung Cancer Patients.” World Journal of Nuclear Medicine, vol. 19, no. 1, Jan. 2020, pp. 8–14. EBSCOhost, https://doi.org/10.4103/wjnm.WJNM_26_19.

APA

Mathew, B., Purandare, N. C., Puranik, A., Shah, S., Agrawal, A., Pramesh, C. S., Karimundackal, G., Jiwnani, S., & Rangarajan, V. (2020). Prognostic value of metabolic parameters measured by 18F-fluorodeoxyglucose positron emission tomography-computed tomography in surgically resected non-small cell lung cancer patients. World Journal of Nuclear Medicine, 19(1), 8–14. https://doi.org/10.4103/wjnm.WJNM_26_19

Chicago

Mathew, Boon, Nilendu C. Purandare, Ameya Puranik, Sneha Shah, Archi Agrawal, C.S. Pramesh, George Karimundackal, Sabita Jiwnani, and Venkatesh Rangarajan. 2020. “Prognostic Value of Metabolic Parameters Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Surgically Resected Non-Small Cell Lung Cancer Patients.” World Journal of Nuclear Medicine 19 (1): 8–14. doi:10.4103/wjnm.WJNM_26_19.